Hybrid coronary revascularization by endoscopic robotic coronary artery bypass grafting on beating heart and stent

Changqing Gao1, Ming Yang, Yang Wu

  • 1Department of Cardiovascular Surgery, PLA General Hospital, PLA Institute of Cardiac Surgery, Beijing, China. gaochq301@yahoo.com

Insights

This study shows that hybrid coronary revascularization, combining robotic bypass surgery on a beating heart with stent placement, is a safe and feasible approach for treating multivessel coronary artery disease.

Area of Science:

  • Cardiovascular Surgery
  • Minimally Invasive Cardiac Surgery
  • Interventional Cardiology

Background:

  • Hybrid revascularization combines minimally invasive coronary artery bypass grafting and percutaneous coronary intervention for multivessel coronary artery disease (CAD).
  • Endoscopic robotic coronary artery bypass grafting on a beating heart is rarely reported.
  • Assessing hybrid revascularization using endoscopic robotic bypass and percutaneous coronary intervention in a staged approach is the study's focus.

Purpose of the Study:

  • To evaluate the feasibility of hybrid coronary revascularization.
  • To assess endoscopic robotic coronary artery bypass grafting on a beating heart combined with percutaneous coronary intervention.
  • To investigate a staged approach for treating multivessel coronary artery disease.

Main Methods:

  • Forty-two patients underwent robotic coronary artery bypass grafting on the beating heart.
  • Ten patients received stent placement after robotic left internal mammary artery (LIMA) to left anterior descending (LAD) artery anastomosis.
  • Percutaneous coronary intervention for non-LAD targets was performed 4-5 days post-surgery.

Main Results:

  • All 10 patients in the hybrid group completed off-pump robotic bypass surgery and stent placement.
  • The staged hybrid approach was performed without any complications.
  • Angiographic assessment confirmed the patency of all LIMA-LAD grafts.

Conclusions:

  • Hybrid coronary revascularization using endoscopic robotic bypass grafting on a beating heart and subsequent stenting is feasible.
  • This integrated, staged approach offers a viable option for patients with multivessel CAD.
  • Preliminary findings support the safety and efficacy of this hybrid strategy.
Abstract